NCT01138111View on ClinicalTrials.gov

Florbetaben (BAY94-9172) PET (Positron Emission Tomography) Imaging in MCI (Mild Cognitive Impairment) Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Alzheimer DiseaseAmyloid Beta-Protein
Interventions
DRUG

Florbetaben (BAY94-9172)

single 300 megabecquerel (MBq) intravenous injection 2 mL to 10 mL, at baseline, at 12 and 24 months

Trial Locations (1)

3084

Heidelberg

Sponsors
All Listed Sponsors
lead

Life Molecular Imaging SA

INDUSTRY